Your browser doesn't support javascript.
loading
Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody.
Piepenbrink, Michael S; Park, Jun-Gyu; Deshpande, Ashlesha; Loos, Andreas; Ye, Chengjin; Basu, Madhubanti; Sarkar, Sanghita; Khalil, Ahmed Magdy; Chauvin, David; Woo, Jennifer; Lovalenti, Philip; Erdmann, Nathaniel B; Goepfert, Paul A; Truong, Vu L; Bowen, Richard A; Walter, Mark R; Martinez-Sobrido, Luis; Kobie, James J.
Afiliación
  • Piepenbrink MS; Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
  • Park JG; Texas Biomedical Research Institute, San Antonio, Texas, United States of America.
  • Deshpande A; Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
  • Loos A; Aridis Pharmaceuticals Inc., Los Gatos, California, United States of America.
  • Ye C; Texas Biomedical Research Institute, San Antonio, Texas, United States of America.
  • Basu M; Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
  • Sarkar S; Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
  • Khalil AM; Texas Biomedical Research Institute, San Antonio, Texas, United States of America.
  • Chauvin D; Aridis Pharmaceuticals Inc., Los Gatos, California, United States of America.
  • Woo J; Aridis Pharmaceuticals Inc., Los Gatos, California, United States of America.
  • Lovalenti P; Aridis Pharmaceuticals Inc., Los Gatos, California, United States of America.
  • Erdmann NB; Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
  • Goepfert PA; Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
  • Truong VL; Aridis Pharmaceuticals Inc., Los Gatos, California, United States of America.
  • Bowen RA; Department of Biomedical Sciences, Colorado State University, Fort Collins, Colorado, United States of America.
  • Walter MR; Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
  • Martinez-Sobrido L; Texas Biomedical Research Institute, San Antonio, Texas, United States of America.
  • Kobie JJ; Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
PLoS Pathog ; 18(7): e1010691, 2022 07.
Article en En | MEDLINE | ID: mdl-35862475
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glicoproteína de la Espiga del Coronavirus / COVID-19 Límite: Animals / Humans Idioma: En Revista: PLoS Pathog Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glicoproteína de la Espiga del Coronavirus / COVID-19 Límite: Animals / Humans Idioma: En Revista: PLoS Pathog Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos